The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year. Lung Cancer, Drugs (Pharmaceuticals), Amgen Inc, Food and Drug Administration, Clinical Trials The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year. NYT > Business
FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancer
